Core Viewpoint - The article highlights the alarming increase in diabetes prevalence in China, emphasizing its significant impact on mortality and life expectancy, particularly among specific demographics such as rural populations and younger individuals [5][8][12]. Summary by Sections Diabetes Prevalence and Impact - Diabetes incidence in China surged 17 times from 0.7% in 1980 to 12.4% in 2018, with over 140 million adult patients by 2021, projected to reach 174 million by 2045 [5]. - The proportion of prediabetic individuals has reached 38.1%, indicating a growing public health concern [5]. Mortality Risks Associated with Diabetes - A study published in "Diabetes Care" revealed that diabetes patients face a 61% higher risk of all-cause mortality and a 59% increased risk of death from cardiovascular diseases (CVD) compared to those with normal blood sugar levels [6][8]. - Even prediabetic individuals experience an 8% and 10% increase in all-cause and CVD mortality risks, respectively [6]. Life Expectancy Reduction - Diagnosis of diabetes at age 40 can reduce life expectancy by approximately 4.2 years for women and 4.3 years for men [8]. - Prediabetic individuals also face a reduction in life expectancy, averaging 0.7 years for those diagnosed at 40 [8]. Cardiovascular Disease Risks - Diabetes patients have a 59% increased risk of death from CVD, with rural patients facing a 75% higher risk compared to urban counterparts [12]. - Younger patients (under 65) are at a higher risk of CVD-related mortality than older patients, with a 89% increase compared to 42% for older groups [12]. Cancer and Other Health Risks - Diabetes patients show a 31% higher overall cancer mortality rate, with specific increases of 40% for lung cancer and 134% for liver cancer [13][14]. - The study emphasizes the need for targeted prevention strategies, especially in rural areas and among younger populations [14]. Recommendations for Action - Establishing a diabetes-CVD prevention and control system in rural areas is crucial [14]. - Clinical treatments should consider the patient's location and age to enhance effectiveness [14]. - There is a strong call for increased public awareness and early screening for blood sugar abnormalities to mitigate health risks [14].